1. Home
  2. TXG vs AHCO Comparison

TXG vs AHCO Comparison

Compare TXG & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • AHCO
  • Stock Information
  • Founded
  • TXG 2012
  • AHCO 2012
  • Country
  • TXG United States
  • AHCO United States
  • Employees
  • TXG N/A
  • AHCO N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • AHCO Medical/Nursing Services
  • Sector
  • TXG Industrials
  • AHCO Health Care
  • Exchange
  • TXG Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • TXG 1.3B
  • AHCO 1.3B
  • IPO Year
  • TXG 2019
  • AHCO N/A
  • Fundamental
  • Price
  • TXG $14.11
  • AHCO $9.44
  • Analyst Decision
  • TXG Buy
  • AHCO Strong Buy
  • Analyst Count
  • TXG 12
  • AHCO 5
  • Target Price
  • TXG $14.13
  • AHCO $13.40
  • AVG Volume (30 Days)
  • TXG 3.7M
  • AHCO 1.3M
  • Earning Date
  • TXG 08-07-2025
  • AHCO 08-05-2025
  • Dividend Yield
  • TXG N/A
  • AHCO N/A
  • EPS Growth
  • TXG N/A
  • AHCO N/A
  • EPS
  • TXG N/A
  • AHCO 0.58
  • Revenue
  • TXG $624,662,000.00
  • AHCO $3,246,360,000.00
  • Revenue This Year
  • TXG N/A
  • AHCO $1.63
  • Revenue Next Year
  • TXG $5.69
  • AHCO $4.44
  • P/E Ratio
  • TXG N/A
  • AHCO $16.38
  • Revenue Growth
  • TXG N/A
  • AHCO N/A
  • 52 Week Low
  • TXG $6.78
  • AHCO $7.11
  • 52 Week High
  • TXG $24.76
  • AHCO $11.90
  • Technical
  • Relative Strength Index (RSI)
  • TXG 68.91
  • AHCO 55.25
  • Support Level
  • TXG $11.45
  • AHCO $9.08
  • Resistance Level
  • TXG $14.16
  • AHCO $9.39
  • Average True Range (ATR)
  • TXG 0.71
  • AHCO 0.38
  • MACD
  • TXG 0.08
  • AHCO 0.01
  • Stochastic Oscillator
  • TXG 93.01
  • AHCO 75.86

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: